SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (20613)5/12/1998 6:49:00 PM
From: Mudcat  Read Replies (4) | Respond to of 32384
 
<INVESTMENT IMPACT: Positive. Considering that Seragen spent over $200 million and Eli Lilly spent at least $20 million on this technology, Ligand's price of $75 million appears cheap.>

What kind of logic does this analyst use? Because $220M was spent by SRGN and Lilly means Lgnd got a good deal at $75M! Who is to say if SRGN spent this money wisely or if the technology actually works? Is this the same analst who predicts the .84 earnings in 1999.